Sickle Cell Disease Drug Development Pipeline Review, 2017

Market-Research
Sickle Cell Disease Drug Development

Sickle cell anemia is a genetic blood disorder in which red blood cells, which carry oxygen around the body, develop abnormally.This report provides an overview of the Sickle Cell Disease pipeline landscape and helps to understand what extent do universities and institutions play a role within this pipeline.